Natco Pharma Limited has informed the Exchange regarding a press release dated September 04, 2024, titled "NATCO Pharma (Canada) Inc., Subsidiary Company of NATCO Pharma Limited announces US$ 8 million investment in eGenesis, Inc.".
Natco Pharma Limited has informed the Exchange regarding a press release dated September 04, 2024, titled "NATCO Pharma (Canada) Inc., Subsidiary Company of NATCO Pharma Limited announces US$ 8 million investment in eGenesis, Inc.".